Leslie Montejano
IBM (United States)(US)
Publications by Year
Research Areas
Substance Abuse Treatment and Outcomes, Opioid Use Disorder Treatment, Schizophrenia research and treatment, Diabetes Treatment and Management, Attention Deficit Hyperactivity Disorder
Most-Cited Works
- → Medication-Assisted Treatment With Methadone: Assessing the Evidence(2013)248 cited
- → Medication-Assisted Treatment With Buprenorphine: Assessing the Evidence(2013)211 cited
- → Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon‐like peptide‐1 receptor agonists: H igher adherence and persistence with dulaglutide compared with once‐weekly exenatide and liraglutide(2017)106 cited
- → Relationship between buprenorphine adherence and relapse, health care utilization and costs in privately and publicly insured patients with opioid use disorder(2018)102 cited
- → Cost of Illness and Comorbidities in Adults Diagnosed With Attention-Deficit/Hyperactivity Disorder(2011)72 cited
- → Factors affecting detoxification readmission: Analysis of public sector data from three states(2006)60 cited
- → Persistence with oral naltrexone for alcohol treatment: implications for health‐care utilization(2008)53 cited
- → Adult ADHD: prevalence of diagnosis in a US population with employer health insurance(2011)48 cited
- → Treatment Patterns and Associated Health Care Costs Before and After Treatment Initiation Among Pulmonary Arterial Hypertension Patients in the United States(2018)47 cited
- → Healthcare Costs Associated with Osteoarthritis in US Patients(2012)39 cited